Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-016508

Chair and CEO sold 6,830 shares at an average $73.58 ($502,577)

  • Chair and CEO acquired 6,830 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-01 Exercise or conversion : show line 1 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-04-01 Sale : show line 2 in the form 10b5-1 −3,021 $72.29 $218,388 237,733 I
2025-04-01 Sale : show line 3 in the form 10b5-1 −772 $73.44 $56,696 236,961 I
2025-04-01 Sale : show line 4 in the form 10b5-1 −2,232 $74.78 $166,909 234,729 I
2025-04-01 Sale : show line 5 in the form 10b5-1 −805 $75.26 $60,584 233,924 I
Open-market sales · 6,830 sh · avg $73.58 · $502,577

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-01 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −6,830 184,480 I
Loading xslF345X05/wk-form4_1743711913.xml…